Biotechnology in Germany - Market Summary, Competitive Analysis and Forecast to 2025
Biotechnology in Germany - Market Summary, Competitive Analysis and Forecast to 2025
SUMMARY
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The German biotechnology market had total revenues of $16.6bn in 2020, representing a compound annual growth rate (CAGR) of 16.7% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $8.3bn, equivalent to 49.7% of the market's overall value.
- Looking forward, market growth is expected to be supported by the upcoming launch of the Future Fund by the German federal government in 2021, which will benefit start-ups in the growth phase in a range of industries, including biotechnology.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
- What was the size of the Germany biotechnology market by value in 2020?
- What will be the size of the Germany biotechnology market in 2025?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. Are there any other notable players in the market?
7.6. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. Merck & Co., Inc.
8.4. BioNTech SE
8.5. MorphoSys AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
7.5. Are there any other notable players in the market?
7.6. How might the COVID-19 pandemic affect the competitive landscape?
8 COMPANY PROFILES
8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. Merck & Co., Inc.
8.4. BioNTech SE
8.5. MorphoSys AG
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Germany biotechnology industry value: $ billion, 2016-20
Table 2: Germany biotechnology industry category segmentation: $ billion, 2020
Table 3: Germany biotechnology industry geography segmentation: $ billion, 2020
Table 4: Germany biotechnology industry value forecast: $ billion, 2020-25
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: Key Employees
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: Annual Financial Ratios
Table 13: Merck & Co., Inc.: Key Employees
Table 14: Merck & Co., Inc.: Key Employees Continued
Table 15: BioNTech SE: key facts
Table 16: BioNTech SE: Annual Financial Ratios
Table 17: BioNTech SE: Key Employees
Table 18: MorphoSys AG: key facts
Table 19: MorphoSys AG: Key Employees
Table 20: Germany size of population (million), 2016-20
Table 21: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 22: Germany gdp (current prices, $ billion), 2016-20
Table 23: Germany inflation, 2016-20
Table 24: Germany consumer price index (absolute), 2016-20
Table 25: Germany exchange rate, 2016-20
Table 1: Germany biotechnology industry value: $ billion, 2016-20
Table 2: Germany biotechnology industry category segmentation: $ billion, 2020
Table 3: Germany biotechnology industry geography segmentation: $ billion, 2020
Table 4: Germany biotechnology industry value forecast: $ billion, 2020-25
Table 5: Bayer AG: key facts
Table 6: Bayer AG: Annual Financial Ratios
Table 7: Bayer AG: Key Employees
Table 8: Bayer AG: Key Employees Continued
Table 9: Boehringer Ingelheim GmbH: key facts
Table 10: Boehringer Ingelheim GmbH: Key Employees
Table 11: Merck & Co., Inc.: key facts
Table 12: Merck & Co., Inc.: Annual Financial Ratios
Table 13: Merck & Co., Inc.: Key Employees
Table 14: Merck & Co., Inc.: Key Employees Continued
Table 15: BioNTech SE: key facts
Table 16: BioNTech SE: Annual Financial Ratios
Table 17: BioNTech SE: Key Employees
Table 18: MorphoSys AG: key facts
Table 19: MorphoSys AG: Key Employees
Table 20: Germany size of population (million), 2016-20
Table 21: Germany gdp (constant 2005 prices, $ billion), 2016-20
Table 22: Germany gdp (current prices, $ billion), 2016-20
Table 23: Germany inflation, 2016-20
Table 24: Germany consumer price index (absolute), 2016-20
Table 25: Germany exchange rate, 2016-20
LIST OF FIGURES
Figure 1: Germany biotechnology industry value: $ billion, 2016-20
Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Germany biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2020
Figure 1: Germany biotechnology industry value: $ billion, 2016-20
Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2020
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2020
Figure 4: Germany biotechnology industry value forecast: $ billion, 2020-25
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2020
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2020
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2020
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2020
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2020
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2020
